Read more information about Lareb and our research about adverse drugs reactions (ADRs)
Home
Actueel
-
10 november 2025Florence van Hunsel appointed as Professor of Pharmacovigilance
Dr. Florence van Hunsel, pharmacist and senior epidemiologist at the Netherlands Pharmacovigilance Centre Lareb, becomes Professor by special appointment of Pharmacovigilance at the University of Gron...
-
09 juli 2025More reports of liver toxicity with Ashwagandha
In September 2023, the Netherlands Pharmacovigilance centre Lareb warned of liver toxicity in people using products containing ashwagandha. Since then, Lareb has received eight new reports. Ashwagandh...
-
24 maart 2025Illegal addition of medication to herbal supplement Montalin once again
Users of the herbal supplement Montalin may unknowingly ingest a corticosteroid. This can lead to unintended and potentially serious consequences. The Dutch Pharmacovigilance Centre Lareb received a r...
View reports
Enter at least the first four letters of the name of the medicine you are looking for in the first search bar. Then choose the right medicine.
If applicable, then select the correct dosage form in the second bar, such as: effervescent tablet, chewable tablet, suppository or oral solution.
What does Lareb do
-
News
Lareb shares information about adverse drug reactions (ADR’s) and other news about safe use of medicines. View all news items on our news items page. -
Teratology Information Service
The Teratology Information Service (TIS) is the knowledge centre of Lareb on safety of drugs used before and during pregnancy and during breastfeeding -
Research activities of Lareb
We continuously conduct research with questionnaires. This way, we learn more about known ADR's of medicines and vaccines and we learn to recognize these earlier.